Baecker A, Liu X, La Vecchia C, Zhang ZF. Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors. Eur J Cancer Prev. 2018;27:205–12.
Cheng M, Bhujwalla ZM, Glunde K. Targeting phospholipid metabolism in cancer. Front Oncol. 2016;6:266.
VanSant-Webb C, Low HK, Kuramoto J, Stanley CE, Qiang H, Su AY, et al. Phospholipid isotope tracing suggests beta-catenin-driven suppression of phosphatidylcholine metabolism in hepatocellular carcinoma. Biochim Biophys Acta Mol Cell Biol Lipids. 2024;1869:159514.
Liu Q, Zhang X, Qi J, Tian X, Dovjak E, Zhang J, et al. Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC. Hepatology. 2024;81:1164–80.
Dai Y, Tang H, Pang S. The crucial roles of phospholipids in aging and lifespan regulation. Front Physiol. 2021;12:775648.
Rysman E, Brusselmans K, Scheys K, Timmermans L, Derua R, Munck S, et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res. 2010;70:8117–26.
Yang Q, Wang L, Liu J, Cao W, Pan Q, Li M. Targeting the complex I and III of mitochondrial electron transport chain as a potentially viable option in liver cancer management. Cell Death Discov. 2021;7:293.
Wheaton WW, Weinberg SE, Hamanaka RB, Soberanes S, Sullivan LB, Anso E, et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. Elife. 2014;3:e02242.
Hsu CC, Wu LC, Hsia CY, Yin PH, Chi CW, Yeh TS, et al. Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs. Oncol Rep. 2015;34:1620–8.
Veiga SR, Ge X, Mercer CA, Hernandez-Alvarez MI, Thomas HE, Hernandez-Losa J, et al. Phenformin-induced mitochondrial dysfunction sensitizes hepatocellular carcinoma for dual inhibition of mTOR. Clin Cancer Res. 2018;24:3767–80.
Levental I, Lyman E. Regulation of membrane protein structure and function by their lipid nano-environment. Nat Rev Mol Cell Biol. 2023;24:107–22.
Liu Z, Zhang Z, Mei H, Mao J, Zhou X. Distribution and clinical relevance of phospholipids in hepatocellular carcinoma. Hepatol Int. 2020;14:544–55.
Krautbauer S, Meier EM, Rein-Fischboeck L, Pohl R, Weiss TS, Sigruener A, et al. Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma. Biochim Biophys Acta. 2016;1861:1767–74.
Muir K, Hazim A, He Y, Peyressatre M, Kim DY, Song X, et al. Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. Cancer Res. 2013;73:4722–31.
van der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Biophys Acta Biomembr. 2017;1859:1558–72.
Bleijerveld OB, Brouwers J, Vaandrager AB, Helms JB, Houweling M. The CDP-ethanolamine pathway and phosphatidylserine decarboxylation generate different phosphatidylethanolamine molecular species. J Biol Chem. 2007;282:28362–72.
Hsu P, Shi Y. Regulation of autophagy by mitochondrial phospholipids in health and diseases. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862:114–29.
Sam PN, Calzada E, Acoba MG, Zhao T, Watanabe Y, Nejatfard A, et al. Impaired phosphatidylethanolamine metabolism activates a reversible stress response that detects and resolves mutant mitochondrial precursors. iScience. 2021;24:102196.
Tasseva G, Bai HD, Davidescu M, Haromy A, Michelakis E, Vance JE. Phosphatidylethanolamine deficiency in Mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphology. J Biol Chem. 2013;288:4158–73.
Selathurai A, Kowalski GM, Mason SA, Callahan DL, Foletta VC, Della Gatta PA, et al. Phosphatidylserine decarboxylase is critical for the maintenance of skeletal muscle mitochondrial integrity and muscle mass. Mol Metab. 2019;27:33–46.
Chen YC, Humphries B, Brien R, Gibbons AE, Chen YT, Qyli T, et al. Functional isolation of tumor-initiating cells using microfluidic-based migration identifies phosphatidylserine decarboxylase as a key regulator. Sci Rep. 2018;8:244.
Humphries BA, Cutter AC, Buschhaus JM, Chen YC, Qyli T, Palagama DSW, et al. Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer. Breast Cancer Res. 2020;22:60.
Thul PJ, Lindskog C. The human protein atlas: a spatial map of the human proteome. Protein Sci. 2018;27:233–44.
Memon A, Pyao Y, Jung Y, Lee JI, Lee WK. A modified protocol of diethylnitrosamine administration in mice to model hepatocellular carcinoma. Int J Mol Sci. 2020;21:5461.
Rodriguez-Rodriguez P, Fernandez E, Bolanos JP. Underestimation of the pentose-phosphate pathway in intact primary neurons as revealed by metabolic flux analysis. J Cereb Blood Flow Metab. 2013;33:1843–5.
Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA. 2010;107:8788–93.
Martinez-Reyes I, Cardona LR, Kong H, Vasan K, McElroy GS, Werner M, et al. Mitochondrial ubiquinol oxidation is necessary for tumour growth. Nature. 2020;585:288–92.
Abbassi-Daloii T, El Abdellaoui S, Kan HE, van den Akker E, T Hoen PAC, Raz V, et al. Quantitative analysis of myofiber type composition in human and mouse skeletal muscles. STAR Protoc. 2023;4:102075.
Sharpley MS, Shannon RJ, Draghi F, Hirst J. Interactions between phospholipids and NADH:ubiquinone oxidoreductase (complex I) from bovine mitochondria. Biochemistry. 2006;45:241–8.
Wu M, Gu J, Guo R, Huang Y, Yang M. Structure of Mammalian Respiratory Supercomplex I(1)III(2)IV(1). Cell. 2016;167:1598–609.e10.
Shinzawa-Itoh K, Aoyama H, Muramoto K, Terada H, Kurauchi T, Tadehara Y, et al. Structures and physiological roles of 13 integral lipids of bovine heart cytochrome c oxidase. EMBO J. 2007;26:1713–25.
Goncalves RL, Quinlan CL, Perevoshchikova IV, Hey-Mogensen M, Brand MD. Sites of superoxide and hydrogen peroxide production by muscle mitochondria assessed ex vivo under conditions mimicking rest and exercise. J Biol Chem. 2015;290:209–27.
Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet. 1995;11:376–81.
Tell G, Vascotto C, Tiribelli C. Alterations in the redox state and liver damage: hints from the EASL Basic School of Hepatology. J Hepatol. 2013;58:365–74.
Zhang Z, Zhao Q, Wang Z, Xu F, Liu Y, Guo Y, et al. Hepatocellular carcinoma cells downregulate NADH:Ubiquinone Oxidoreductase Subunit B3 to maintain reactive oxygen species homeostasis. Hepatol Commun. 2024;8:e0395.
Xing L, Tang Y, Li L, Tao X. ROS in hepatocellular carcinoma: What we know. Arch Biochem Biophys. 2023;744:109699.
Chen W, Zhao H, Li Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Sig Transduct Target Ther. 2023;8:333.
Huang Q, Zhan L, Cao H, Li J, Lyu Y, Guo X, et al. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy. 2016;12:999–1014.
Wang W, Lu J, Zhu F, Wei J, Jia C, Zhang Y, et al. Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells. Med Oncol. 2012;29:70–6.
Ma M, Lin XH, Liu HH, Zhang R, Chen RX. Suppression of DRP1‑mediated mitophagy increases the apoptosis of hepatocellular carcinoma cells in the setting of chemotherapy. Oncol Rep. 2020;43:1010–8.
Feng N, Zhang R, Wen X, Wang W, Zhang N, Zheng J, et al. RABIF promotes hepatocellular carcinoma progression through regulation of mitophagy and glycolysis. Commun Biol. 2024;7:1333.
Pan KH, Chang H, Yang WY. Extracellular release in the quality control of the mammalian mitochondria. J Biomed Sci. 2023;30:85.
Ma L, Li Y, Peng J, Wu D, Zhao X, Cui Y, et al. Discovery of the migrasome, an organelle mediating release of cytoplasmic contents during cell migration. Cell Res. 2015;25:24–38.
Jiao H, Jiang D, Hu X, Du W, Ji L, Yang Y, et al. Mitocytosis, a migrasome-mediated mitochondrial quality-control process. Cell. 2021;184:2896–910.e13.
Lyamzaev KG, Nepryakhina OK, Saprunova VB, Bakeeva LE, Pletjushkina OY, Chernyak BV, et al. Novel mechanism of elimination of malfunctioning mitochondria (mitoptosis): formation of mitoptotic bodies and extrusion of mitochondrial material from the cell. Biochim Biophys Acta. 2008;1777:817–25.
Nakajima A, Kurihara H, Yagita H, Okumura K, Nakano H. Mitochondrial Extrusion through the cytoplasmic vacuoles during cell death. J Biol Chem. 2008;283:24128–35.
Healy ME, Chow JD, Byrne FL, Breen DS, Leitinger N, Li C, et al. Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine. J Hepatol. 2015;62:599–606.
Healy ME, Lahiri S, Hargett SR, Chow JD, Byrne FL, Breen DS, et al. Dietary sugar intake increases liver tumor incidence in female mice. Sci Rep. 2016;6:22292.
Heden TD, Chow LS, Hughey CC, Mashek DG. Regulation and role of glycophagy in skeletal muscle energy metabolism. Autophagy. 2022;18:1078–89.
McCall CP, Mancini MC, Staszkiewicz J, Mashek DG, Heden TD. Heterozygous GAA knockout is nonconsequential on metabolism and the spatial liver transcriptome in high-fat diet-induced obese and prediabetic mice. Physiol Rep. 2025;13:e70276.
Heden TD, Franklin MP, Dailey C, Mashek MT, Chen C, Mashek DG. ACOT1 deficiency attenuates high-fat diet induced fat mass gain by increasing energy expenditure. JCI Insight. 2023;8:e160987.
Heden TD, Chen C, Leland G, Mashek MM, Najt CP, Shang L, et al. Isolated and combined impact of dietary olive oil and exercise on markers of health and energy metabolism in female mice. J Nutr Biochem. 2022;107:109040.
Choi JY, Black R 3rd, Lee H, Di Giovanni J, Murphy RC, Ben Mamoun C, et al. An improved and highly selective fluorescence assay for measuring phosphatidylserine decarboxylase activity. J Biol Chem. 2020;295:9211–22.
Huynh FK, Green MF, Koves TR, Hirschey MD. Measurement of fatty acid oxidation rates in animal tissues and cell lines. Methods Enzymol. 2014;542:391–405.
Huang TY, Zheng D, Houmard JA, Brault JJ, Hickner RC, Cortright RN. Overexpression of PGC-1alpha increases peroxisomal activity and mitochondrial fatty acid oxidation in human primary myotubes. Am J Physiol Endocrinol Metab. 2017;312:E253–E63.
Huang TY, Linden MA, Fuller SE, Goldsmith FR, Simon J, Batdorf HM, et al. Combined effects of a ketogenic diet and exercise training alter mitochondrial and peroxisomal substrate oxidative capacity in skeletal muscle. Am J Physiol Endocrinol Metab. 2021;320:E1053–E67.
Huang TY, Goldsmith FR, Fuller SE, Simon J, Batdorf HM, Scott MC, et al. Response of liver metabolic pathways to ketogenic diet and exercise are not additive. Med Sci Sports Exerc. 2020;52:37–48.
Comments (0)